Antibiotic

Items 1001-1050 of 1401

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. Antibiotic

    Ramoplanin is a broad-spectrum lipoglycodepsipeptide antibiotic that targets gram-positive bacteria. Derived from Actinoplanes species, it exhibits potent antimicrobial activity, making it effective against various resistant strains. This compound is significant for research applications focusing on antibiotic resistance mechanisms and the development of novel antimicrobial therapies.
  2. Antibiotic

    Hygromycin A is a spirochete-specific antibiotic targeting Borrelia burgdorferi, the causative agent of Lyme disease. It exhibits potent antibacterial activity against spirochetes, making it a valuable tool for research into Lyme disease and gut health. Hygromycin A is suitable for studies investigating spirochete pathogenesis and potential therapeutic interventions.
  3. Antibiotic

    Cefetamet is a cephalosporin antibiotic that functions by binding to bacterial penicillin-binding proteins (PBPs), with an IC50 of 2.5 μg/mL for PBP3 in Escherichia coli W3110. It exhibits significant antibacterial activity against a variety of Gram-negative bacteria, including Enterobacteriaceae, Neisseria species, and Haemophilus influenzae, as well as Gram-positive bacteria such as Streptococcus. Additionally, Cefetamet demonstrates bactericidal effects against Treponema pallidum. This compound is valuable for researching respiratory, urinary, and ear, nose, and throat infections, in addition to syphilis.
  4. Antibiotic Agent

    Oxytetracycline hydrochloride is an antibiotic from the tetracycline class, primarily targeting bacterial protein synthesis. It effectively inhibits both Gram-negative and Gram-positive bacteria by preventing the binding of aminoacyl-tRNA to the mRNA-ribosomal RNA complex. Additionally, oxytetracycline hydrochloride exhibits anti-HSV-1 activity, making it valuable for research applications in microbiology and virology.
  5. Polypeptide Antibiotic

    Colistin is a polypeptide antibiotic primarily targeting Gram-negative bacteria. It demonstrates potent activity against multidrug-resistant strains such as Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae. Due to its nephrotoxic potential, careful consideration is required during research. Colistin is valuable for studying infections caused by Gram-negative bacilli and exploring antibiotic resistance mechanisms.
  6. Antibiotic

    Penicillin V, also known as Phenoxymethylpenicillin, is a potent, orally bioavailable antibiotic targeting bacterial cell wall synthesis. It exhibits significant antibacterial activity against Streptococci, Clostridium difficile, and Staphylococcus aureus. This compound is valuable for research applications related to otitis, sinusitis, pharyngitis, and tonsillitis, providing insights into bacterial pathogenesis and resistance mechanisms.
  7. Antibiotic

    Cefacetrile is a broad-spectrum antibiotic with activity against both gram-positive and gram-negative bacteria. It targets bacterial cell wall synthesis, inhibiting peptidoglycan cross-linking, which leads to cell lysis and death. This compound is primarily utilized in research involving bacterial infections and offers valuable insights into antibiotic mechanisms and resistance.
  8. Lipoglycopeptide Antibiotic

    Dalbavancin is a semisynthetic lipoglycopeptide antibiotic targeting Gram-positive bacteria. It exhibits potent bactericidal activity, with minimal inhibitory concentrations (MIC90) of 0.06 μg/mL against Staphylococcus aureus and 0.25 μg/mL against Bacillus anthracis. This compound is primarily utilized in research applications focused on bacterial infections and the development of novel antimicrobial therapies.
  9. Antibiotic

    Micronomicin is an aminoglycoside antibiotic that exerts its effects primarily by binding to bacterial ribosomal RNA, leading to disruption of protein synthesis. This compound exhibits significant antibacterial and bactericidal activity against a wide range of Gram-negative and some Gram-positive bacteria. Micronomicin is utilized in research applications related to antibiotic resistance, infection models, and the study of microbial pathogenesis.
  10. Antibiotic

    Telavancin hydrochloride is an antibiotic that functions primarily by inhibiting cell wall synthesis and disrupting cell membrane barrier function. This semisynthetic derivative of vancomycin demonstrates significant antibacterial activity against antibiotic-resistant Staphylococcus aureus strains, including MRSA, VISA, and hVISA. Telavancin hydrochloride is particularly effective in treating complicated skin and skin structure infections (cSSSI) caused by gram-positive bacteria. This compound is valuable for research into antibiotic resistance and the development of novel antimicrobial therapies.
  11. Lincosamide Antibiotic

    Lincomycin is a lincosamide antibiotic that targets bacterial protein synthesis by inhibiting the 50S ribosomal subunit. It exhibits potent antimicrobial activity against a range of Gram-positive bacteria, making it invaluable in studying bacterial infections and resistance mechanisms. Lincomycin is commonly used in research applications focusing on microbial pathogenesis and the development of antibiotic resistance.
  12. Antibiotic

    Djalonensone is an antibiotic compound isolated from the roots of Anthocleista djalonensis (Loganiaceae). It exhibits significant antimicrobial activity, making it a valuable tool in research focused on developing new antibiotic therapies. Its unique properties also serve as an important taxonomic marker for the identification and classification of this plant species.
  13. Antibiotic

    Bleomycin B4 is an antibiotic that exhibits potent antitumor activity. It functions by inducing DNA strand breaks, leading to cell cycle arrest and apoptosis in cancer cells. This compound is commonly utilized in cancer research to explore therapeutic strategies and mechanisms of action in oncology.
  14. Antibiotic

    Enduracidin is a polypeptide antibiotic that exerts its antibacterial effects by inhibiting cell wall synthesis in susceptible bacteria. Originally derived from Streptomyces fungicides, this compound is effective against a range of Gram-positive organisms. Enduracidin is primarily utilized in research applications focused on antibiotic resistance and the development of novel antibacterial agents.
  15. Antibiotic

    Kasugamycin is an antibiotic that targets the ribosomal subunits by binding to both the 30S and 70S ribosomes, without interacting with isolated 50S subunits. It mimics mRNA nucleotides, leading to destabilization of tRNA binding and inhibition of canonical translation initiation. This compound is valuable for research in antibiotic mechanisms, ribosomal function, and the study of bacterial protein synthesis.
  16. Antibiotic

    Thiolactomycin is an antibiotic that targets the FabB enzyme, effectively inhibiting the synthesis of fatty acids and mycolic acids. This compound demonstrates potent activity against Gram-negative anaerobes and exhibits inhibitory effects on malaria parasites and trypanosomes. It is a valuable reagent for researchers investigating antibiotic mechanisms and fatty acid biosynthesis pathways, as well as for studies focused on protozoan infections.
  17. Polypeptide Antibiotics

    Polymyxin B2 is a polypeptide antibiotic that primarily targets the cell membrane of gram-negative bacteria. It exerts its antibacterial effect by binding to lipopolysaccharide components, leading to membrane disruption and subsequent cell lysis. This compound is relevant for antibiotic research and development, particularly in addressing drug-resistant bacterial strains.
  18. Macrolide Antibiotic

    Venturicidin A is a macrolide antibiotic that acts as a potent inhibitor of ATP synthase. Derived from actinomycetes, it enhances the efficacy of the aminoglycoside antibiotic gentamicin against multidrug-resistant strains of Staphylococcus, Enterococcus, and Pseudomonas aeruginosa. Although Venturicidin A demonstrates significant antibacterial activity, it also exhibits notable toxicity towards human embryonic kidney (HEK) cells, with an IC50 value of 31 μg/mL, making it a valuable compound for research in antibiotic resistance and cellular response assessments.
  19. Antibiotic

    Benzylideneacetone operates as an orally active antibiotic with a primary mechanism of inhibiting tyrosinase and phospholipase A2. It demonstrates antibacterial activity against select gram-negative plant-pathogenic bacteria, making it a valuable compound for agricultural research. Additionally, Benzylideneacetone serves as a versatile starting material in the synthesis of chemicals and pharmaceuticals, and it is utilized as a flavoring additive in certain food applications.
  20. Quinolone Antibiotic

    Nemonoxacin malate is a nonfluorinated quinolone antibiotic that targets bacterial DNA gyrase and topoisomerase IV. This compound demonstrates broad-spectrum antimicrobial activity against Gram-positive, Gram-negative, and atypical pathogens, including drug-resistant Streptococcus pneumoniae and Methicillin-resistant Staphylococcus aureus. Nemonoxacin malate is valuable for research focused on community-acquired pneumonia and other infections where antibiotic resistance is a concern.
  21. Linker-Antibiotic Intermediate

    MC-VC-PAB-O-Gemcitabine is a linker-antibiotic intermediate specifically designed for use in antibody-antibiotic conjugate (AAC) applications. This compound features a conjugation with the antibiotic Gemcitabine, facilitating targeted delivery and enhancing the therapeutic potential against bacterial infections. Its utility in research encompasses the exploration of immunotherapy strategies and the development of novel antibacterial agents.
  22. Cephalosporin Antibiotic

    Ceftolozane TFA is a cephalosporin antibiotic that targets Gram-negative bacteria by disrupting cell wall synthesis. Its potent antibacterial activity makes it a valuable tool in combating resistant infections. Ceftolozane TFA can be utilized in research aimed at developing novel antibiotics with improved efficacy and safety profiles.
  23. Antibiotic Peptide

    Aurein 1.2 is an antibiotic peptide derived from amphibian sources, exhibiting potent antimicrobial and anticancer properties. This peptide targets bacterial membranes, leading to disruption and cell death, making it valuable in the study of antibiotic resistance and cancer therapeutics. Aurein 1.2 is ideal for research applications focused on the development of novel antimicrobial agents and exploring mechanisms of cancer cell apoptosis.
  24. Aminoglycoside Antibiotic

    Neamine is an aminoglycoside antibiotic and a degradation product of Neomycin, known for its broad-spectrum antibacterial properties. It exerts anti-angiogenic effects by targeting angiogenin, making it valuable in cancer research. Additionally, Neamine demonstrates neuroprotective and antitumor activities, supporting its potential in diverse biological studies.
  25. β-Lactam Antibiotic

    Cephalothin is a semi-synthetic cephalosporin antibiotic classified as a β-lactam antibiotic. It exerts its antibacterial activity by inhibiting class C β-lactamase AmpC with a Ki of 0.32 µM while also binding to penicillin-binding proteins, thereby disrupting the cross-linking of peptidoglycan in the bacterial cell wall. This mechanism impedes bacterial cell wall synthesis, allowing it to effectively target a broad spectrum of bacteria. Cephalothin is applicable in studies related to hematology and nephrotoxicity.
  26. Cephem Antibiotic

    Cefcapene pivoxil hydrochloride is a pivalate ester prodrug of Cefcapene, functioning as a third-generation cephalosporin antibiotic. It demonstrates a broad spectrum of antibacterial activity, making it valuable in various microbiological studies. Additionally, this compound may hold potential for research applications related to palmoplantar pustulosis (PPP).
  27. Antitumor Antibiotic/AdoHcy hydrolase Inhibitor

    Neplanocin A is an antitumor antibiotic that functions as an irreversible inhibitor of AdoHcy hydrolase, with a Ki of 8.39 nM. It exhibits significant antitumor activity against murine L1210 leukemia cells and also demonstrates antiviral properties, notably against the vaccinia virus. This compound is isolated from the marine-derived organism Ampulariella regularis, making it a valuable reagent for research in cancer therapeutics and virology.
  28. Antibiotic

    Avrainvillamide is a naturally occurring alkaloid that functions as an antibiotic by targeting the nuclear chaperone nucleophosmin (NPM1), which is often overexpressed in various human tumors. This compound exhibits antiproliferative properties by directly binding to NPM1 and Crm1, and disrupting their interactions with native cellular partners. Avrainvillamide demonstrates strong antibacterial activity against multi-drug resistant strains of Staphylococcus aureus, Streptococcus pyogenes, and Enterococcus faecalis, with minimum inhibitory concentrations (MICs) of 12.5, 12.5, and 25 μg/ml, respectively. Its unique mechanism and efficacy make it a valuable tool in antibiotic research and cancer biology studies.
  29. Gentamicin-Type Antibiotic

    Micronomicin sulfate is a gentamicin-type aminoglycoside antibiotic derived from Micromonospora. It exhibits broad-spectrum antibacterial activity, particularly effective against Pseudomonas, Proteus, Klebsiella pneumoniae, and Serratia, with MIC values ranging from 0.001 to 8.3 μg/ml. This compound is utilized in research focused on bacterial infections and antibiotic resistance mechanisms, making it a valuable tool in microbiological studies and drug development.
  30. Carbapenem Antibiotic

    Meropenem-vaborbactam is a carbapenem antibiotic combined with a boronic acid-based beta-lactamase inhibitor, designed to effectively combat Enterobacteriaceae, particularly Klebsiella pneumoniae strains producing carbapenemases. This compound demonstrates notable in vitro activity against Pseudomonas aeruginosa, with MIC50 values of 0.5 μg/mL and MIC90 values of 8 μg/mL, making it a valuable tool for research in antimicrobial resistance and the development of new therapeutic strategies.
  31. Antibiotic

    Virginiamycin Complex is a synergistic antibiotic comprised of two streptogramins, virginiamycin M (VM) and virginiamycin S (VS), derived from Streptomyces virginiae. This complex effectively irreversibly inhibits protein synthesis in bacteria, leveraging the persistent and catalytic action of VM to enhance the affinity of ribosomes for VS. Virginiamycin Complex exhibits significant antibacterial activity and is applied in research focused on studying bacterial resistance mechanisms and developing novel antimicrobial strategies.
  32. antibiotic

    Etimicin sulfate is a fourth-generation aminoglycoside antibiotic that primarily targets bacterial protein synthesis by binding to the 30S ribosomal subunit. It exhibits potent antibacterial activity against a broad spectrum of Gram-negative and Gram-positive bacteria, making it valuable in treating various infections. Etimicin sulfate is particularly useful in clinical settings due to its high efficacy and low toxicity profile.
  33. Antibiotic for Poultry

    Tylosin phosphate is a macrolide antibiotic that targets Gram-positive bacteria, exhibiting significant antimicrobial activity. It is commonly used as a feed additive in veterinary applications to promote growth in poultry, pigs, and cattle. Tylosin phosphate is effective in treating bacterial dysentery and respiratory diseases, making it an essential reagent in veterinary medicine and animal health research.
  34. Antibiotic

    CRS3123 is a potent, orally active narrow-spectrum antibiotic that specifically targets bacterial methionyl-tRNA synthetase. It demonstrates significant efficacy against Clostridium difficile and aerobic Gram-positive bacteria while exhibiting minimal activity against Gram-negative bacteria, including anaerobes. CRS3123 is a valuable reagent for research focused on C. difficile infections and their treatment options.
  35. Antibiotic

    Nemonoxacin is a potent, orally active broad-spectrum antibiotic that primarily targets bacterial infections. It demonstrates significant inhibitory effects against various species, including staphylococci, streptococci, enterococci, Neisseria gonorrhoeae, and Haemophilus influenza. This compound is valuable for research applications related to bacterial infections and the study of community-acquired pneumonia.
  36. Antibiotic

    Cefodizime is a third-generation cephalosporin antibiotic that exhibits a broad spectrum of antibacterial activity. It is characterized by its low renal toxicity and favorable tolerance profile, along with immune modulation capabilities. This compound is particularly useful in the treatment of severe infections affecting the respiratory and urinary tracts.
  37. Antibiotic

    Platensimycin is an antibiotic derived from Streptomyces platensis that selectively inhibits the biosynthesis of cellular lipids in gram-positive bacteria. It targets the β-ketoacyl-acyl-carrier-protein synthase I/II enzymes, FabF/B, with IC50 values of 48 nM and 160 nM for Staphylococcus aureus and Escherichia coli, respectively. With its unique mechanism of action, Platensimycin shows potential as a therapeutic agent to combat antibiotic resistance.
  38. Fluoroquinolone Antibiotic

    Grepafloxacin hydrochloride is a fluoroquinolone antibiotic that exhibits potent activity against community-acquired respiratory pathogens, particularly Streptococcus pneumoniae. This compound demonstrates high tissue penetration and a favorable pharmacodynamic profile, making it suitable for research applications focused on antimicrobial resistance and respiratory infections. Its unique properties allow for the investigation of effective treatment strategies in microbiology and pharmacology research.
  39. Antibiotic

    Spiramycin I is a macrolide antibiotic that primarily targets bacterial protein synthesis by inhibiting the 50S ribosomal subunit. It exhibits significant antibacterial and antiparasitic activity, making it useful in the treatment of various infections. This reagent is valuable for research applications focused on antimicrobial resistance mechanisms and the development of new therapeutic strategies.
  40. Antibiotic

    Anhydrotetracycline is an antibiotic that functions primarily through the inhibition of tetracycline destructases, thereby preserving the activity of tetracycline antibiotics. This compound demonstrates dose-dependent potency, making it a valuable tool for studying antibiotic resistance mechanisms and enhancing the efficacy of tetracycline-based therapies. Its application in molecular biology and microbiology research helps elucidate bacterial response to antibiotic treatment.
  41. Antibiotic

    Sanfetrinem sodium is a beta-lactamase-stable antibiotic that targets bacterial cell wall synthesis. It exhibits broad-spectrum antibacterial activity against both gram-positive and gram-negative bacteria, making it a valuable reagent for research applications aimed at understanding bacterial resistance mechanisms and developing new antimicrobial therapies.
  42. β-Lactam Antibiotic

    Loracarbef hydrate is a β-lactam antibiotic that belongs to the carbacephem class, exhibiting a synthetic origin. This second-generation cephalosporin antibiotic demonstrates significant antibacterial activity against a variety of Gram-positive and selected Gram-negative bacteria. It is primarily utilized in research applications focused on microbiology and antibiotic resistance studies.
  43. Antibiotic

    Levonadifloxacin is a broad-spectrum antibiotic that targets bacterial infections, particularly against staphylococcal strains. It exhibits potent antibacterial activity against both Methicillin-susceptible Staphylococcus aureus (MSSA) and Methicillin-resistant S. aureus (MRSA). This compound is valuable for research applications focused on the mechanisms of antibiotic resistance and the efficacy of therapeutic strategies in treating resistant infections.
  44. Antibiotic

    Kendomycin ((−)-TAN 2162) is a polyketide antibiotic primarily targeting bacterial growth inhibition. It exhibits significant antibacterial activity, particularly against methicillin-resistant Staphylococcus aureus (MRSA) with a minimum inhibitory concentration (MIC) of 5 μg/mL. In addition to its antibacterial properties, Kendomycin acts as a potent antagonist of the endothelin receptor and a calcitonin receptor agonist, highlighting its potential applications in anti-osteoporotic research.
  45. Antibiotic

    AMOZ, a metabolite associated with Furaltadone, functions as an antibiotic by forming stable tissue residues through covalent binding to proteins. This property allows for the coupling of AMOZ with carrier proteins, such as BSA or OVA, to elicit an immune response and release upon acid hydrolysis. AMOZ is instrumental in monitoring antibiotic residues in animal-derived foods, with detection capabilities via competitive ELISA methods achieving limits as low as 0.16 μg/kg in shrimp samples. Its utility makes it a critical marker in food safety research.
  46. Antibiotic

    PAMAM Dendrimer G0.0 amine is an antibiotic targeting pore-forming toxins, specifically acting as an antagonist to anthrax toxin protective antigen 63 (PA63, IC50 = 231 nM) and C. botulinum C2 toxin subunit (C2IIa, IC50 = 940 nM). At concentrations of 10 and 20 µM, it demonstrates protective effects against C2 toxin-induced cytotoxicity in HeLa cells. Additionally, this compound acts as a nickel chelator and has been employed in the selective capture and storage of carbon dioxide in gas-feed systems when used in conjunction with polysulfone membrane-bound chitosan. PAMAM Dendrimer G0.0 amine serves as a valuable reagent in research focused on infectious diseases, cancer biology, and drug delivery systems.
  47. Glycopeptide Antibiotic

    A40926 is a glycopeptide antibiotic that targets the bacterial cell wall peptidoglycan precursor D-alanyl-D-alanine (D-Ala-D-Ala). It functions by irreversibly inhibiting cell wall synthesis through competitive binding, demonstrating significant bactericidal activity against Gram-positive bacteria, including Staphylococcus and Streptococcus, as well as Neisseria gonorrhoeae, with MIC values ranging from 0.06 to 2 μg/mL. Additionally, A40926 is effective against penicillin-resistant strains, disrupting peptidoglycan cross-linking and leading to bacterial lysis and death. The compound's fat-soluble fatty acid structure enhances serum concentrations and extends its duration of action, with a terminal half-life of 61.22 hours in rats.
  48. Antibiotic Peptide

    Dermcidin-1L (human) is an antibiotic peptide that targets microbial pathogens with its inherent antimicrobial activity. Secreted by sweat glands, it plays a crucial role in skin defense mechanisms. Research applications include studies of inflammatory skin disorders and the investigation of innate immune responses.
  49. Antibiotic

    Indolmycin is a competitive inhibitor of prokaryotic tryptophanyl-tRNA synthetase (TrpS), serving as an effective antibiotic. This compound exhibits significant antibacterial and antiviral properties, making it valuable in various research applications focused on microbial resistance and viral infection mechanisms. Its unique mode of action allows for exploration into strategies for combating infectious diseases.
  50. Antibiotic

    Ristocetin A sulfate is an antibiotic primarily targeting staphylococcal infections. Its biological activity includes promoting thrombocytopenia and platelet agglutination. Ristocetin A sulfate is instrumental in two important assays: the ristocetin cofactor assay and the ristocetin-induced platelet aggregation assay, both of which are utilized in diagnosing von Willebrand disease and various bleeding disorders.

Items 1001-1050 of 1401

Page
per page
Set Descending Direction